164 related articles for article (PubMed ID: 38625542)
1. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
Zhang B; Zhang LX; Yi J; Wang CH; Zhao Y
Arch Gynecol Obstet; 2024 Apr; ():. PubMed ID: 38625542
[TBL] [Abstract][Full Text] [Related]
2. First-trimester absent nasal bone: is it a predictive factor for pathogenic CNVs in the low-risk population?
Fantasia I; Stampalija T; Sirchia F; Della Pietà I; Ottaviani Giammarco C; Guidolin F; Quadrifoglio M; Barresi V; Travan L; Faletra F
Prenat Diagn; 2020 Dec; 40(12):1563-1568. PubMed ID: 32799336
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency.
Wang C; Tang J; Tong K; Huang D; Tu H; Zhu J
J Hum Genet; 2022 Sep; 67(9):533-539. PubMed ID: 35578003
[TBL] [Abstract][Full Text] [Related]
4. Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency.
Xie X; Zhou H; Zhao Q; Lu Y; Meng Y
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6213-6218. PubMed ID: 34649482
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
[TBL] [Abstract][Full Text] [Related]
6. Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study.
Coello-Cahuao E; Sánchez-Durán MÁ; Calero I; Higueras MT; García MA; Rodó C; Maiz N; Plaja Rustein A; Castells-Sarret N; Mediano-Vizuete C; Carreras E
Arch Gynecol Obstet; 2023 Jan; 307(1):285-292. PubMed ID: 35486155
[TBL] [Abstract][Full Text] [Related]
7. When NIPT meets WES, prenatal diagnosticians face the dilemma: genetic etiological analysis of 2,328 cases of NT thickening and follow-up of pregnancy outcomes.
Ji X; Li Q; Qi Y; Wang X; Ding H; Lu J; Zhang Y; Yin A
Front Genet; 2023; 14():1227724. PubMed ID: 37600658
[No Abstract] [Full Text] [Related]
8. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
Du L; Xie HN; Zheng J; He M
Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
[No Abstract] [Full Text] [Related]
9. Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic Technology.
Xue S; Yan H; Chen J; Li N; Wang J; Liu Y; Zhang H; Li S; Zhang W; Chen D; Chen M
Cytogenet Genome Res; 2020; 160(2):57-62. PubMed ID: 32036363
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency.
Cicatiello R; Pignataro P; Izzo A; Mollo N; Pezone L; Maruotti GM; Sarno L; Sglavo G; Conti A; Genesio R; Nitsch L
Med Sci (Basel); 2019 Feb; 7(3):. PubMed ID: 30818867
[TBL] [Abstract][Full Text] [Related]
11. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review.
Petersen OB; Smith E; Van Opstal D; Polak M; Knapen MFCM; Diderich KEM; Bilardo CM; Arends LR; Vogel I; Srebniak MI
Acta Obstet Gynecol Scand; 2020 Jun; 99(6):765-774. PubMed ID: 32306377
[TBL] [Abstract][Full Text] [Related]
12. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
Ni M; Li J; Zhu X; Zhu Y; Gu L; Wu X; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):970-974. PubMed ID: 31598938
[TBL] [Abstract][Full Text] [Related]
13. Application of non-invasive prenatal testing in screening chromosomal aberrations in pregnancies with different nuchal translucency cutoffs.
Xu Y; Hu S; Chen L; Hao Y; Zhang H; Xu Z; Wu W; Deng L
Mol Cytogenet; 2023 Oct; 16(1):29. PubMed ID: 37898768
[TBL] [Abstract][Full Text] [Related]
14. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
Hui L; Pynaker C; Bonacquisto L; Lindquist A; Poulton A; Kluckow E; Hutchinson B; Norris F; Pertile MD; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Am J Obstet Gynecol; 2021 Nov; 225(5):527.e1-527.e12. PubMed ID: 33957116
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Chromosomal Microarray Analysis and Noninvasive Prenatal Testing in Pregnant Women with Fetal Ultrasonic Soft Markers.
Hu X; Hu Y; Wang H; Yu C; Zheng J; Zhang H; Zheng J
Risk Manag Healthc Policy; 2024; 17():29-40. PubMed ID: 38196919
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis.
Di Girolamo R; Rizzo G; Khalil A; Alameddine S; Lisi G; Liberati M; Novelli A; D'Antonio F
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2193285. PubMed ID: 37019452
[TBL] [Abstract][Full Text] [Related]
17. Application of chromosomal microarray in fetuses with increased nuchal translucency.
Zhao XR; Gao L; Wu Y; Wang YL
J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
[No Abstract] [Full Text] [Related]
18. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
[TBL] [Abstract][Full Text] [Related]
19. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
20. The clinical impact of the first-trimester nuchal translucency between the 95th-99th percentiles.
Fantasia I; Catagini S; Zamagni G; Greco P; Bianchini I; Bussolaro S; Quadrifoglio M; Lo Bello L; Monasta L; Ricci G; Faletra F; Feresin A; Stampalija T
Prenat Diagn; 2023 Jun; 43(7):929-936. PubMed ID: 37264704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
